Ph.D. William Benton Jones - 20 Dec 2022 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role: SVP, Pharmaceutical Development
Signature: /s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
Issuer symbol: CRVS
Transactions as of: 20 Dec 2022
Net transactions value: +$15,800
Form type: 4
Filing time: 20 Dec 2022, 17:22:25 UTC
Previous filing: 15 Aug 2022
Next filing: 08 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRVS	Common Stock	Purchase	$15,800	+20,000	+18%	$0.7900	133,773	20 Dec 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

SVP, Pharmaceutical Development